No Carolina / New York / Florida        Ph: 561.316.3330

American College of Cardiology Supports FDA Efforts to End Access to Menthol Cigarettes, Flavored Cigars

What To Know

  • “Tobacco use is the leading cause of preventable death in the United States and a significant, modifiable risk factor for heart disease, which is the No.
  • The American College of Cardiology is heartened to see the FDA's recent commitment to advance bans on menthol flavored cigarettes and all flavored cigars.

American College of Cardiology President Dipti Itchhaporia, MD, FACC, made the following statement on the U.S. Food and Drug Administration’s (FDA) commitment to ban menthol cigarettes and flavored cigarettes.

“Tobacco use is the leading cause of preventable death in the United States and a significant, modifiable risk factor for heart disease, which is the No. 1 cause of death in the United States. This should give us ample reason to take every action available to reduce tobacco’s impact on our society and public health. The American College of Cardiology is heartened to see the FDA’s recent commitment to advance bans on menthol flavored cigarettes and all flavored cigars. The ACC has joined with stakeholders in recent years to call for this change as an imperative to public health.

It is already known that flavored products are often targeted at and used by our youth population. It is why flavored e-cigarettes have already been banned and why we have raised the age to use tobacco products to 21.

We all understand the stakes of tobacco products and addiction on our communities’ health. Menthol cigarettes are well-known to increase youth initiation to smoking; they also increase addiction to nicotine and reduce success in smoking cessation.

We also know that menthol cigarettes have an incredibly high toll in the disease and death in the Black community, worsening existing and unacceptable health disparities. The ACC, the public health community, the FDA and Congress must work together on this vital issue with clear public health benefits of reducing tobacco-related death and disease.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

"The programs selected for an AAOS IDEA Grant will help to cultivate meaningful and measurable opportunities across orthopaedics, acting as a springboard for change within our profession," said AAOS Diversity Advisory Board Chair Holly Tyler-Paris Pilson, MD, FAAOS, FAOA. "This is not about checking a box; this call for proposals opens a door for funding directly to the local and regional orthopaedic programs and organizations who are training the current and next generation."
In a 10-center study, microwave ablation offered progression-free survival rates and fewer complications than surgery in the treatment of a form of thyroid cancer known as papillary thyroid carcinoma (PTC), according to research published today in Radiology, a journal of the Radiological Society of North America (RSNA).
Robert J. Lewandowski said, “Throughout the last 50 years, SIR has enabled the specialty to grow in an evolving healthcare landscape, providing IRs with the education, resources, and support required for members to thrive. As we look forward, SIR remains committed to fostering healthcare innovations that improve patients’ lives worldwide.”
The ACC has selected 50 learners for its 2024 – 2025 Clinical Trials Research program, of whom 28 structural heart cardiologists and surgeons will participate in the CTR’s new Project REACH. This incoming cohort of learners will participate in a year-long curriculum designed to advance their skills and careers in clinical trials research and ensure that all individuals have the opportunity to contribute as part of the clinical trials research workforce.
Radiology Advances joins RSNA’s suite of peer-reviewed journals that includes the Society’s flagship journal, Radiology, education journal, RadioGraphics, and subspecialty journals, Radiology: Artificial Intelligence, Radiology: Cardiothoracic Imaging and Radiology: Imaging Cancer.

By using this website you agree to accept Medical Device News Magazine Privacy Policy